NAPROSYN Detail

Drug Name(s):
NAPROSYN

FDA Application No.:
NDA 018965

Active Ingredient(s):
NAPROXEN

Company:
ROCHE PALO

Original Approval or Tentative Approval Date:
March 22, 1987

Products on Application NDA 018965:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
NAPROXEN	25MG/ML	SUSPENSION; ORAL	Prescription	AB

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	November 2008
S	M	T	W	T	F	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Who's online

There are currently 0 users and 432 guests online.

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

We comply with the HONcode standard for health trust worthy information:
verify here.

last updated on 11-21-2008

Links to Site

NAPROSYN Detail

Hot Topics

Sponsored Links

Recall Notices

Action Alerts

Most Recent Content

Active forum topics

Poll

Subscribe to our feed